Alliance Pharma (APH)

 

APH Share PerformanceMore

52 week high59.00 07/10/15
52 week low40.50 27/06/16
52 week change -10.00 (-17.54%)
4 week volume13,114,083 01/09/16

Latest NewsMore

Director Deals - Alliance Pharma PLC (APH)

John Dawson, Chief Executive Officer, sold 3,000,000 shares in the company on the 22nd September 2016 at a price of 45.25...

Exercise of Share Options

RNS Number: 6202K Alliance Pharma PLC 23 September 2016 For immediate release 23 September 2016 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Exercise of Share Options Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that following the exercise of employee share options, application has been made by Allian...

Director Dealings

RNS Number: 6200K Alliance Pharma PLC 23 September 2016 For immediate release 23 September 2016 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Director Dealings Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, was notified on 22 September 2016 that, on the same day, John Dawson, Chief Executive Officer of the Comp...

Are these 2 healthcare stocks ‘screaming buys’?

Alliance Pharma (LSE:APH) and Advanced Medical Solutions (LSE:AMS) have both released upbeat results today giving u...

Alliance revenues up 104%

Alliance Pharma's revenues for the six months to the end of June rose by 104% to 46.4m. It said ex-Sinclair products had m...

Interim Results

RNS Number: 7587J Alliance Pharma PLC 14 September 2016 For immediate release 14 September 2016 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Interim Results for the six months ended 30 June 2016 Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce its interim results for the six months ended 30 June 2...

New Agreement for Diclectin in Europe

RNS Number: 6255J Alliance Pharma PLC 13 September 2016 For immediate release 13 September 2016 ALLIANCE PHARMA PLC ("Alliance" or the "Group") New Agreement for Diclectin in Key European Countries Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce that it has signed a further licensing and distributio...

3 hot dates for your September investment diaries

August has been a busy month for company news, but what does September have to offer? It's going to be quieter, but we...

Fundamental DataMore

P/E ratio10.108
EPS4.65
Dividend yield2.34 %

Equity Research (APH)

hardman & co
Alliance Pharma plc
07/06/2016
Alliance Pharma has adopted a buy-and-build strategy to evolve through a series of 28 acquisitions into a profitable, cash generative, specialty pharma business. The acquisition of part of the...
hardman & co
Alliance Pharma plc
07/01/2016
Feature Article: Survey shows underlying strengths in wealth manager business models By Keith Hiscock, C.E.O. The survey recently published by ComPeer of wealthy investors has some surprising...
Alliance Pharma plc
16/10/2015
Our August edition of the life sciences review ‘The Biotech Feast - after the party comes the hangover’ warned that those at the top of the life sciences tree were showing signs of calling the end of...

Latest discussion posts More

  • Re: 3m shares

    Like anyone else, even CEO's may wish to upgrade their private lives,, their house, their kids' schooling etc. A nagging wife often sees to that. Meantime, here, he ...
    23-Sep-2016
    winningstreak
  • Re: 3m shares

    This does not exactly fill the investors and potential investors with a confidence. nk
    23-Sep-2016
    nk1999
  • 3m shares

    CEO Dawson sold 3m shares (keeping 56m shares. See RNS. institutional demand must have precipitated the sale. We may get another RNS to inform us which Institution has ...
    23-Sep-2016
    winningstreak

Users' HoldingsMore

Users who hold Alliance Pharma also hold..
LLOYDS GRP.26%
BP19%
TESCO17%
GLAXOSMITHKLINE13%
NATIONAL GRID13%

Codes & Symbols

ISINGB0031030819
SymbolsAPH, LSE:APH, APH.L, APH:LN, LON:APH, XLON:APH